DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Pappas Ventures names Michael Grey Venture Partner
News | 01. 11. 2010
Pappas Ventures today announced that industry veteran Michael Grey has been named a venture partner.
